van Vollenhoven, R.

Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations

Aletaha, D., Landewe, R., Karonitsch, T., Bathon, J., Boers, M., Bombardier, C., Bombardieri, S., Choi, H., Combe, B., Dougados, M., et al. (2008) · Arthritis Care & Research

Rheumatoid Arthritis Research and TherapiesStatistical Methods in Clinical Trials

Cited by 214

Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes

Choi, M. Y., Chen, I., Clarke, A. E., Fritzler, M. J., Buhler, K. A., Urowitz, M., Hanly, J., St-Pierre, Y., Gordon, C., Bae, S.-C., et al. (2023) · Annals of the Rheumatic Diseases

Systemic Lupus Erythematosus ResearchSystemic Sclerosis and Related Diseases

Cited by 89

CD28nullCD4+ T Cells – Characterization of an Effector Memory T‐Cell Population in Patients with Rheumatoid Arthritis

Fasth, A. E. R., Cao, D., Van Vollenhoven, R., Trollmo, C., & Malmström, V. (2004) · Scandinavian Journal of Immunology

T-cell and B-cell ImmunologyRheumatoid Arthritis Research and Therapies

Cited by 73

Antimitochondrial antibodies in systemic lupus erythematosus are associated with and predict nephritis, arterial vascular events, and mortality

Becker, Y. L. C., Boilard, É., Rollet-Labelle, E., Lood, C., Julien, A.-S., Abrahamowicz, M., Allaeys, I., Choi, M., Leclerc, J., Lévesque, T., et al. (2026) · Annals of the Rheumatic Diseases

Systemic Lupus Erythematosus ResearchSystemic Sclerosis and Related Diseases

Cited by 3